Improvements in Chromatographic Performance for Stability Indicating Methods of Antiviral Drugs with MaxPeak Premier Technology

Importance of the Topic

Robust stability-indicating chromatographic methods are essential in pharmaceutical analysis to ensure that trace-level drug impurities, including potentially genotoxic or highly active degradation products, are reliably detected and quantified. Antiviral compounds such as Tenofovir and its prodrug Tenofovir Alafenamide Fumarate present analytical challenges due to their interaction with metal surfaces in conventional HPLC systems, which can lead to poor peak shape, reduced sensitivity, and incomplete recovery at low concentrations.

Objectives and Study Overview

This application note evaluates the impact of Waters® MaxPeak Premier Technology on chromatographic performance for stability-indicating analysis of antiviral drug products. The study compares conventional stainless-steel HPLC systems and columns with the MaxPeak Premier-enabled systems, focusing on key performance indicators: peak shape, sensitivity, recovery of low-level degradation products, and compliance with regulatory impurity thresholds.

Methodology

The study applied a gradient HPLC method using ammonium formate buffer (pH 4.0) and acetonitrile over a 10.5-minute run. Forced degradation of Tenofovir Alafenamide Fumarate included thermal and oxidative stress conditions. Reference and degraded samples were analyzed under three configurations: conventional system with standard column, conventional system with MaxPeak Premier column, and MaxPeak Premier system with MaxPeak Premier column.

Instrumentation

• LC system 1: ACQUITY Arc with Quaternary Solvent Manager, Sample Manager, Column Manager, Empower 3 software
• LC system 2: Arc Premier with Quaternary Solvent Manager, Premier Sample Manager, Empower 3 software
• Detector: ACQUITY Photodiode Array (PDA) at 260 nm
• Columns: XBridge XP BEH C18 (2.5 µm, 4.6×150 mm) and XBridge Premier BEH C18 (2.5 µm, 4.6×150 mm)
• Conditions: 43 °C column, 20 °C sample, 1.3 mL/min flow, 5 µL injection

Results and Discussion

MaxPeak Premier Technology significantly improved the chromatographic response of Tenofovir reference standards and forced-degradation samples. Compared to conventional setups, peak area and height increased by up to 4.5-fold for trace-level Tenofovir, while peak tailing and width decreased, enabling automated integration. Recovery of degraded Tenofovir in control samples rose from just above the 0.1% reporting threshold to over 0.4%, and oxidative degradation recoveries improved similarly.

Benefits and Practical Applications

• Enhanced sensitivity for trace impurities without strong mobile-phase chelators or lengthy passivation
• Improved peak shape and signal-to-noise ratio facilitate reliable quantitation
• Supports regulatory compliance by exceeding impurity reporting requirements

Future Trends and Opportunities

As pharmaceutical analysis advances, demand for metal-inert chromatography will grow, especially for ion-sensitive and reactive drug substances. Integration of MaxPeak Premier concepts with automated method development and quality-by-design (QbD) workflows may further streamline stability-indicating method optimization and regulatory approval processes.

Conclusion

MaxPeak Premier Technology addresses metal-induced analyte loss and peak distortion in conventional HPLC, delivering substantial gains in sensitivity, peak integrity, and quantitative reliability for antiviral drug stability analysis. Its adoption can improve low-level impurity detection and simplify method development for critical pharmaceutical workflows.

Reference

1. Plumb R. and Wilson I., Metal-Analyte Interactions – An Unwanted Distraction, The Column, 2021.
2. DeLano M., et al., Analytical Chemistry, 93(14), 2021.
3. ICH Q1A(R2), Stability Testing of New Drug Substances and Products, 2003.
4. FDA Guidance for Industry #5, Drug Stability Guidelines, 21 CFR 211.
5. Golla V.M., et al., Journal of Pharmaceutical and Biomedical Analysis, 131, 2016.
6. Layton C.E. and Rainville P.D., Waters Application Note 720007480EN, 2021.
7. ChemSpider, 2D Structure Database, accessed 2021.
8. Arsenault J.C. and McDonald P., Beginner’s Guide to Liquid Chromatography, Waters Primer, 2007.